Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Terminated 2 Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Genitourinary 2 Gastrointestinal 2 Classical hematology 2 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 CNS 1

Conditions

Leukemia, B-Cell 1

Interventions

Cytarabine 465 Cyclophosphamide 459 fludarabine phosphate 277 Rituximab 249 Methotrexate 245 Etoposide 203 fludarabine 200 Filgrastim 199 Peripheral Blood Stem Cell Transplantation 180 Busulfan 169 Vincristine 163 Dexamethasone 153 Daunorubicin 151 Azacitidine 145 Mycophenolic Acid 142 Whole-Body Irradiation 133 Tacrolimus 127 Imatinib Mesylate 127 Cyclosporine 123 Granulocyte Colony-Stimulating Factor 118 Radiotherapy 113 Melphalan 110 Idarubicin 103 Doxorubicin 101 Mitoxantrone 97 Decitabine 97 Antilymphocyte Serum 97 Lenalidomide 96 Mercaptopurine 93 Prednisone 91

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ciprofloxacin × Other hematologic neoplasm × Clear all

NCT01279252 2019-01-25

CLEAR

King's College Hospital NHS Trust

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡